Stocktoria

Scholar Rock Holding Corp SRRK

Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-05-24
Chart by TradingView
1/9
Piotroski F — financial health
-9.91
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Valuation · market cap as of 2026-06-29

Market cap$6.6B
P / B26.7×

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$0$33.2M$18.8M
Operating income-$384.6M-$252.1M-$171.3M-$134.4M-$129.9M
Net income-$377.9M-$246.3M-$165.8M-$134.5M-$131.8M
Operating cash flow-$300.0M-$200.9M-$145.2M-$132.7M-$126.8M
Free cash flow-$300.6M-$201.0M-$145.3M-$133.8M-$132.0M
Total assets$404.3M$474.9M$311.0M$358.2M$304.4M
Total liabilities$158.8M$106.3M$85.8M$97.9M$132.4M
Shareholders' equity$245.5M$368.6M$225.2M$260.2M$172.1M
Ratios
Operating margin-404.8%-690.5%
Net margin-405.2%-700.5%
FCF margin-403.0%-701.7%
Return on assets-93.5%-51.9%-53.3%-37.6%-43.3%
Return on equity-154.0%-66.8%-73.6%-51.7%-76.6%
Debt / equity0.41×0.14×0.22×0.19×0.28×
Current ratio6.959.618.809.014.13
Revenue growth76.4%22.2%

Notable holders (13F)

InvestorSharesValue
Point72 Asset Management, L.P.15,200$747,232

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -9.91 (distress)

  • Working capital / assets 0.816
  • Retained earnings / assets -3.217
  • EBIT / assets -0.951
  • Equity / liabilities 1.546

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001727196 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.